Effect of neoadjuvant chemotherapy on the immune microenvironment in non–small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches

BACKGROUND: The clinical efficacy observed with inhibitors of programed cell death 1/programed cell death ligand 1 (PD-L1/PD-1) in cancer therapy has prompted studies to characterize the immune response in several tumor types, including lung cancer. However, the immunological profile of non–small ce...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Immunother Cancer
Auteurs principaux: Parra, Edwin R., Villalobos, Pamela, Behrens, Carmen, Jiang, Mei, Pataer, Apar, Swisher, Stephen G., William, William N., Zhang, Jiexin, Lee, Jack, Cascone, Tina, Heymach, John V., Forget, Marie-Andrée, Haymaker, Cara, Bernatchez, Chantale, Kalhor, Neda, Weissferdt, Annikka, Moran, Cesar, Zhang, Jianjun, Vaporciyan, Ara, Gibbons, Don L., Sepesi, Boris, Wistuba, Ignacio I.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2018
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5989476/
https://ncbi.nlm.nih.gov/pubmed/29871672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0368-0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires